Ambarella, Inc. — Q3 Fiscal 2024 Form 10-Q
Reporting period: Three and nine months ended October 31, 2023. The company develops low-power semiconductor system-on-chips for video, image processing, AI and computer vision applications, including IoT cameras, automotive, industrial and robotics markets.
Financial performance
| Metric | Three months ended Oct. 31 | Nine months ended Oct. 31 |
|---|---|---|
| Revenue | $50.6 million, down 39.1% year over year | $174.9 million, down 31.2% |
| Gross profit / margin | $30.0 million / 59.3% (62.2% prior year) | $106.0 million / 60.6% (62.6% prior year) |
| Operating loss | $42.0 million (prior year: $20.1 million) | $112.8 million (prior year: $50.8 million) |
| Net loss | $41.7 million; $1.04 per diluted share | $108.8 million; $2.74 per diluted share |
| Operating cash flow | Not separately provided for the quarter | $23.1 million (prior year: $39.0 million) |
For the nine months, research and development expense was $163.1 million, up 7.4%; selling, general and administrative expense was $55.8 million, down 4.2%. Other income was $3.9 million for the nine months, primarily reflecting higher interest income.
Liquidity, debt and balance sheet
At October 31, 2023, cash and cash equivalents were $143.8 million and marketable debt securities were $78.5 million, totaling $222.3 million in cash, cash equivalents and marketable securities. This compares with $206.9 million at January 31, 2023. Total current assets were $279.8 million and current liabilities $75.8 million. The filing reports no borrowings; operating lease liabilities totaled $5.9 million. Management said existing cash balances should meet anticipated cash requirements for at least the next 12 months.
Nine-month investing cash flow was positive $5.1 million, reflecting investment maturities and sales, partly offset by purchases of investments and tangible and intangible assets. Financing cash flow was positive $2.1 million. The company had $49.0 million remaining under its share repurchase authorization through June 30, 2024; it made no repurchases during the period.
Changes, outlook and notable items
- Revenue declines reflected lower product shipments as customers reduced inventories, along with lower nonrecurring engineering services. Continued adoption of higher-average-selling-price computer-vision products partly offset the decline.
- Gross margin fell amid unfavorable product mix, lower NRE services, higher assembly and intangible amortization costs, and inventory reserves. Operating losses widened as lower gross profit coincided with elevated development spending.
- Management said customers were making progress on inventory reduction and expected conditions to become more stable in future periods, but gave no specific revenue or earnings guidance in the provided filing text. It expects R&D spending to rise as it develops AI and computer-vision products and targets new markets.
- Customer concentration is significant: WT accounted for 52.2% of nine-month revenue and Chicony 13.9%. For the quarter, WT, Hakuto and Chicony represented 53.7%, 12.0% and 11.7%, respectively.
- The company depends on third-party manufacturing, primarily in Asia, and has no long-term agreements with those contractors. It disclosed $26.2 million of manufacturing purchase commitments and $7.5 million of estimated future cash payments for software licenses.
- Unusual items included a $1.2 million impairment of an equity investment in Q2, workforce-reduction severance charges, and a $4.0 million tax benefit from releasing a valuation allowance on Oculii deferred tax assets. The CFO’s separation agreement provides for continued service through January 31, 2024 and approximately $1.9 million of additional stock-based compensation through that date.
- Risks highlighted include continued customer destocking and demand volatility, reliance on a major distributor and a small customer base, export restrictions and U.S.-China tensions, supply-chain and foundry capacity constraints, and the uncertainty of converting design wins in automotive, robotics and other new markets into revenue. No material legal proceedings were reported.
Key facts for investors to verify
- Whether customer inventory reductions are nearing completion and shipments recover as expected.
- Whether computer-vision adoption and new-market design wins translate into sustained revenue and improved margins.
- The effects of customer and distributor concentration, export controls, and third-party manufacturing dependence on future sales and supply.
- Whether operating cash generation can support continued R&D investment and commitments if losses persist.
- The timing and financial impact of the CFO transition, stock-based compensation, and remaining share repurchase authorization.